Wave Life Sciences Ltd.
Wave Life Sciences Ltd. (WVE) Revenue
Annual & quarterly revenue history · segment & region breakdown
WVE · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsWave Life Sciences Ltd. trailing twelve-month (TTM) revenue is $0.07B, a decrease of 60.55% year-over-year from $0.04B in FY2025.
Revenue trend
2025 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.04B | -$0.07B | -60.55% |
| 2024-12-31 | $0.11B | -$0.01B | -4.42% |
| 2023-12-31 | $0.11B | +$0.11B | +3005.10% |
| 2022-12-31 | $0.00B | -$0.04B | -91.09% |
| 2021-12-31 | $0.04B | +$0.02B | +104.03% |
| 2020-12-31 | $0.02B | +$0.00B | +25.61% |
| 2019-12-31 | $0.02B | +$0.00B | +10.89% |
| 2018-12-31 | $0.01B | +$0.01B | +289.15% |
| 2017-12-31 | $0.00B | +$0.00B | +149.43% |
| 2016-12-31 | $0.00B | +$0.00B | +876.97% |
Compare revenue vs peers
BiotechnologyCompare WVE revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Wave Life Sciences Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Wave Life Sciences Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Wave Life Sciences Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
WVE revenue · 4 questionsWVE's trailing twelve-month (TTM) revenue is $0.07B. That is a decrease of 60.55% year-over-year from $0.04B in FY2025.
▸ Source: FMP · Wave Life Sciences Ltd. SEC filings · GAAP · Wave Life Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026